Meanwhile, TZ‐dSA3‐12 successfully delivered dSA3 to tumor sites and robustly synergistically activated STING signaling in both tumor cells and myeloid cells through the Fab and Fc regions of antibodies. Here, STING1 is linked to neoplasm.